Navigation Links
CareFusion Corporation Launches International Jazz Festival Series
Date:7/7/2009

NEW YORK, July 7 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public following the planned spinoff of Cardinal Health's clinical and medical products businesses, today announced the CareFusion Jazz Festival Series at an event held in New York.

CareFusion created the CareFusion Jazz Festival Series to support the launch of its new brand and recognize individuals and organizations working to improve patient care. The new medical technology company combines its proven technologies with information to help measurably improve the delivery of care.

The Series comprises some of the largest and oldest jazz festivals in the world, attracting both big-name and up-and-coming artists.

"There is a clear connection between jazz and medicine that provides the perfect opportunity to launch our new brand, raise funds for and awareness of patient safety and help support and preserve the arts," said David Schlotterbeck, CEO of CareFusion. "Both jazz and the practice of medicine embrace innovation, performance and change. Jazz has also been used to teach listening skills to medical students and resonates with our customers. In addition, the musicians playing at these festivals are the best and the brightest - a great fit for our company whose products are recognized as leaders in our industry."

George Wein, world-famous jazz impresario and founder of the Newport Jazz Festival said, "This is a critical time to invest in the arts. CareFusion is re-igniting a 34-year tradition in New York City and supporting cultural institutions around the world."

The CareFusion Jazz Festival Series will open in Newport, R.I. The kickoff event will be George Wein's CareFusion Jazz Festival 55, the oldest of the festivals and the one that has set the tradition for jazz festivals as they are known today. The full schedule includes:

  • George Wein's CareFusion Jazz Festival 55 (Newport, R.I.), Aug. 7 - 9, 2009
  • Chicago Jazz Festival presented by CareFusion, Sept. 4 - 6, 2009
  • CareFusion Presents Dizzy's Den at the Monterey Jazz Festival, Sept. 18 - 20, 2009
  • CareFusion Manly Jazz Festival (Australia), Oct. 3 - 5, 2009
  • CareFusion Jazz Festival Paris, Oct. 16 - 24, 2009
  • CareFusion New York Jazz Festival, June 2010 (exact dates to be determined)

As part of the Festival Series, CareFusion will broadcast live to hospitals the performances of select festival artists. Caregivers and administrators from hospitals across the United States, Europe and Australia will also be invited to special VIP events at the festivals to raise funds and awareness for a new health care safety campaign named Rhythm of Care.

Rhythm of Care will bring together organizations and people from health care to promote best practices and honor safety leaders working to improve how care is delivered worldwide.

Medication errors and hospital-acquired infections are two of the biggest challenges facing the medical industry. Reports cite the annual cost of medication errors to be $3.5 billion in the U.S. and $3 billion per year in top five European countries. In addition, there are an estimated 7 million hospital-acquired infections worldwide annually, costing as much as $20 billion per year in the U.S alone.

"Building a safer and more efficient approach to health care is a top priority for everyone - hospitals, caregivers, patients and government," said Schlotterbeck. "That is why CareFusion plans to partner with nonprofit safety organizations to create Rhythm of Care. We want to honor individuals in health care that are pioneering new ways to improve safety and share their ideas with others."

About CareFusion Corporation

CareFusion Corporation, a wholly owned subsidiary of Cardinal Health (NYSE: CAH), is expected to become a public company from the planned spinoff of Cardinal Health's clinical and medical products businesses. The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of health care. CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, AVEA and Pulmonetic Systems ventilation and respiratory products, ChloraPrep(R) and MedMined(TM) services for infection prevention, neurological monitoring and diagnostic products, V. Mueller(R) surgical instruments, and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has applied to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at www.carefusion.com.

About George Wein

Jazz Impresario and NEA Jazz Master George Wein is considered to be as much a legend as his festivals. Through his company, Festival Productions, he has spearheaded hundreds of music events annually since 1954 when he produced the first Newport Jazz Festival - an event that started the "festival era," according to jazz critic Leonard Feather. At 83, Wein has as much creative fuel as he did when he started that festival and advanced the concept of live music. He pioneered the concept of sponsor association with music events and continues that tradition with CareFusion. Honors and awards have been bestowed upon him by AARP, Studio Museum of Harlem, Presidents Bill Clinton and Jimmy Carter, the Government of France and other organizations around the world. Wein's autobiography, Myself Among Others: A Life in Music, which chronicles his life in jazz, was recognized by the Jazz Journalists Association as 2004's best book about jazz. He has also been named 2009's Events Producer of the Year. In addition to his life in jazz, Wein has a long history of involvement with philanthropy and the arts.

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing the planned spinoff of Cardinal Health's clinical and medical products businesses as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Files Amended Form 10 Registration Statement With SEC
2. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
3. CareFusion Names Robert Friel to Board of Directors
4. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
5. CareFusion Names Edward Borkowski as Chief Financial Officer
6. CareFusion Corporation Files Form 10 Registration Statement
7. AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31
8. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
9. Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimers Immunotherapy Program and Equity Investment
10. Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc.
11. Baxa Corporations Dennis Tribble, PharmD, Now Profiled at Expert411.com for Media and Professional Access
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has released a new publication this ... of the Savior whom the world calls “Mother Mary”. Yisrayl says when compared to what ... historical woman. , “The world bows, kisses the feet of, cries out to and ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... 15, 2017  AOTI Inc. announced today that its fully owned ... recently opened a New York City Office in Yonkers, ... unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This new ... for Health Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable ... Advanced ...
(Date:8/8/2017)... AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: ... immunology, today reports its financial results for the second ... achievements during the second quarter 2017 and to date: ... multiple clinical development programs for the Company,s lead project, ... 3 pivotal study with BL-8040 as novel stem cell ...
Breaking Medicine Technology: